Text-based approach for detecting cases of ADEs from EHRs of participants of the Estonian Biobank

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Informatics in Medicine Unlocked

• Publication date

  2025-11-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.imu.2025.101701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review

  2025cited by this paper
• Genetic influences on antidepressant side effects: a CYP2C19 gene variation and polygenic risk study in the Estonian Biobank

  2025cited by this paper
• Large Language Models for Adverse Drug Events: A Clinical Perspective

  2025cited by this paper
• Effectiveness of Transformer-Based Large Language Models in Identifying Adverse Drug Reaction Relations from Unstructured Discharge Summaries in Singapore

  2025cited by this paper
• Combined effect of CYP2C19 and CYP2D6 genotypes on escitalopram serum concentration and its metabolic ratio in a European patient population

  2024cited by this paper
• Repeatable process for extracting health data from HL7 CDA documents

  2024cited by this paper
• Detection of Patient-Level Immunotherapy-Related Adverse Events (irAEs) from Clinical Narratives of Electronic Health Records: A High-Sensitivity Artificial Intelligence Model

  2024cited by this paper
• The Estonian Biobank’s journey from biobanking to personalized medicine

  2024cited by this paper
• Adverse drug event detection using natural language processing: A scoping review of supervised learning methods

  2023cited by this paper
• AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events

  2023cited by this paper
• Automated stance detection in complex topics and small languages: The challenging case of immigration in polarizing news media

  2023cited by this paper
• Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants

  2023cited by this paper
• Drug-related causes attributed to acute kidney injury and their documentation in intensive care patients.

  2023cited by this paper
• CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability.

  2022cited by this paper
• Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissions

  2022cited by this paper
• Artificial intelligence in pharmacology research and practice

  2022cited by this paper
• Serotonin Transporter Genetic Variation and Antidepressant Response and Tolerability: A Systematic Review and Meta-Analysis

  2021cited by this paper
• Advances in Genomic Discovery and Implications for Personalized Prevention and Medicine: Estonia as Example

  2021cited by this paper
• Severe Adverse Drug Reactions to Quetiapine in Two Patients Carrying CYP2D6*4 Variants: A Case Report

  2021cited by this paper
• 2018 N2c2 Shared Task on Adverse Drug Events and Medication Extraction in Electronic Health Records

  2020cited by this paper
• EstNLTK 1.6: Remastered Estonian NLP Pipeline

  2020cited by this paper
• New insights into quetiapine metabolism using molecular networking

  2020cited by this paper
• Influence of CYP2C19 Metabolizer Status on Escitalopram/Citalopram Tolerability and Response in Youth With Anxiety and Depressive Disorders

  2019cited by this paper
• Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

  2019cited by this paper
• Overview of the First Natural Language Processing Challenge for Extracting Medication, Indication, and Adverse Drug Events from Electronic Health Record Notes (MADE 1.0)

  2019cited by this paper
• Pharmacogenomics Clinical Annotation Tool (PharmCAT)

  2019cited by this paper
• Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model

  2018cited by this paper
• MIMIC-III, a freely accessible critical care database

  2016cited by this paper
• Cohort Profile Cohort Profile : Estonian Biobank of the Estonian Genome Center , University of Tartu

  2015cited by this paper
• Epidemiology of Adverse Drug Reactions in Europe: A Review of Recent Observational Studies

  2015cited by this paper
• Interrater reliability: the kappa statistic

  2012cited by this paper
• Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes

  2009cited by this paper
• Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients

  2004cited by this paper

• No citing papers are available for this paper.